Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
MALAT1 and diabetes mellitus are reported together in 4 articles.
Gene
MALAT1
- HGNC
- HGNC:29665
32articles
32mentions
2variants with confirmed gene link
Most co-reported phenotypes (articles)
diabetes mellitus 4breast cancer 2colorectal cancer 2gastric cancer 2hypertension 2lung cancer 2systemic lupus erythematosus 2Crohn disease 1
Reported variants (articles · ClinVar status)
Phenotype
Diabetes mellitus
2,156articles
2,156mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
4 records shown · first 60Associations of MALAT1 rs619586/rs3200401 and ANRIL rs10965215/rs10738605 polymorphisms with type 2 diabetes and diabetic nephropathy risk in an Egyptian population.
PMID 42428670 | PMCID PMC13346653 | DOI 10.3389/fendo.2026.1802490 · Frontiers in endocrinology · 2026 · 6 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | MALAT1 | “Associations of MALAT1 rs619586/rs3200401 and ANRIL rs10965215/rs10738605 polymorphisms with type 2 diabetes and diabetic nephropathy risk in an Egyptian population.” | 0.98 | hgnc_dict_v1 |
| phenotype | diabetes mellitus | “Associations of MALAT1 rs619586/rs3200401 and ANRIL rs10965215/rs10738605 polymorphisms with type 2 diabetes and diabetic nephropathy risk in an Egyptian population.” | 0.93 | phenotype_alias_lexicon_v2 |
| variant | rs619586 | “Associations of MALAT1 rs619586/rs3200401 and ANRIL rs10965215/rs10738605 polymorphisms with type 2 diabetes and diabetic nephropathy risk in an Egyptian population.” | 0.90 | hgvs_regex_v1 |
| variant | rs3200401 | “Associations of MALAT1 rs619586/rs3200401 and ANRIL rs10965215/rs10738605 polymorphisms with type 2 diabetes and diabetic nephropathy risk in an Egyptian population.” | 0.90 | hgvs_regex_v1 |
Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1.
PMID 38199135 | DOI 10.1016/j.prp.2023.155041 · Pathology, research and practice · 2024 · 8 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | MALAT1 | “Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1.” | 0.98 | hgnc_dict_v1 |
| phenotype | diabetes mellitus | “This review aims to elucidate the complex role of MALAT1 in autoimmune disorders, encompassing rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease (Crohn's disease and ulcerative colitis), type 1 diabetes, systemic lupus erythematosus, and psoriasis.” | 0.93 | phenotype_alias_lexicon_v2 |
| phenotype | inflammatory bowel disease | “This review aims to elucidate the complex role of MALAT1 in autoimmune disorders, encompassing rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease (Crohn's disease and ulcerative colitis), type 1 diabetes, systemic lupus erythematosus, and psoriasis.” | 0.98 | phenotype_alias_lexicon_v2 |
| phenotype | ulcerative colitis | “This review aims to elucidate the complex role of MALAT1 in autoimmune disorders, encompassing rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease (Crohn's disease and ulcerative colitis), type 1 diabetes, systemic lupus erythematosus, and psoriasis.” | 0.98 | phenotype_alias_lexicon_v2 |
Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.
PMID 33436407 | PMCID PMC7805373 | DOI 10.1136/bmjdrc-2020-001821 · BMJ open diabetes research & care · 2021 · 6 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | MALAT1 | “Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.” | 0.98 | hgnc_dict_v1 |
| phenotype | diabetes mellitus | “Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | NKILA | “Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.” | 0.98 | hgnc_dict_v1 |
| gene | NEAT1 | “Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.” | 0.98 | hgnc_dict_v1 |
Long Non-Coding RNAs Gene Variants as Molecular Markers for Diabetic Retinopathy Risk and Response to Anti-VEGF Therapy.
PMID 34429633 | PMCID PMC8374537 | DOI 10.2147/PGPM.S322463 · Pharmacogenomics and personalized medicine · 2021 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | MALAT1 | “PURPOSE: For the first time, we aimed to evaluate the association of four lncRNAs TUG1 (rs7284767G/A), MIAT (rs1061540T/C), MALAT1 (rs3200401C/T), and SENCR (rs12420823C/T) variants with susceptibility to diabetic retinopathy (DR), disease severity, and early therapeutic response to intravitreous anti-vascular endothelial growth factor aflibercept therapy.” | 0.98 | hgnc_dict_v1 |
| phenotype | diabetes mellitus | “PATIENTS AND METHODS: This case-control study enrolled 126 adult patients with type 2 diabetes.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | TUG1 | “PURPOSE: For the first time, we aimed to evaluate the association of four lncRNAs TUG1 (rs7284767G/A), MIAT (rs1061540T/C), MALAT1 (rs3200401C/T), and SENCR (rs12420823C/T) variants with susceptibility to diabetic retinopathy (DR), disease severity, and early therapeutic response to intravitreous anti-vascular endothelial growth factor aflibercept therapy.” | 0.98 | hgnc_dict_v1 |
| gene | MIAT | “PURPOSE: For the first time, we aimed to evaluate the association of four lncRNAs TUG1 (rs7284767G/A), MIAT (rs1061540T/C), MALAT1 (rs3200401C/T), and SENCR (rs12420823C/T) variants with susceptibility to diabetic retinopathy (DR), disease severity, and early therapeutic response to intravitreous anti-vascular endothelial growth factor aflibercept therapy.” | 0.98 | hgnc_dict_v1 |